/
Pharmaceutical preparations company · E9 · FY ends Dec · Revenue $8M · -279.48% margin · -$16M FCF
The business is unprofitable at the operating level (-279.48% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 7332.8% YoY with margins expanding 34555.9pp.
Negative free cash flow of -$16M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$8M
▲ +7332.8% YoY
Net Income (TTM)
-$18M
▲ +47.3% YoY
Op. Margin
-279.48%
▲ +34555.9pp YoY
ROIC
-33.37%
▲ +3.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$16M
▲ +47.3% YoY
Op. Cash Flow (TTM)
-$16M
▲ +47.3% YoY
Net Debt
-$73M
Net Cash Position
Cash & Equiv.
$75M
5Y CAGR: +61.4%
Continue Research